Trial Profile
A 24-week study to evaluate the etanercept levels and disease activity in patients with ankylosing spondylitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 12 Dec 2015 New trial record